4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Forte Biosciences, Inc. (FBRX) operates in the Biotechnology industry and is headquartered in Dallas, United States with about 22 employees. Its market capitalization is roughly $750 million. In the fiscal year ended 2025-12-31, FBRX reported $0M in revenue and ($69M) in net income.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($71M) | ($37M) | ($32M) | ($14M) | — |
| Net Income | ($69M) | ($36M) | ($32M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($22M) | ($25M) | ($18M) | ($12M) | ($16M) |
| Net Income | ($22M) | ($25M) | ($18M) | ($11M) | ($16M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $83M | $62M | $39M | $42M | — |
| Total Liabilities | $22M | $9M | $4M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FBRX viewer.
About TickerBase · Data methodology & sources